The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26337433)

Published in Eur J Clin Microbiol Infect Dis on September 04, 2015

Authors

M Kussmann1, L Schuster1, M Zeitlinger2, P Pichler3, G Reznicek4, M Wiesholzer3, H Burgmann5, W Poeppl1,6

Author Affiliations

1: Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
2: Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria.
3: Department of Internal Medicine I, University Hospital St. Poelten, Karl Landsteiner University of Health Sciences, St. Poelten, Austria.
4: Department of Pharmacognosy, University of Vienna, Vienna, Austria.
5: Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. heinz.burgmann@meduniwien.ac.at.
6: Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Articles cited by this

Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int (2010) 12.06

The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol (1986) 4.09

ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int (2011) 3.88

Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro. Antimicrob Agents Chemother (1975) 3.43

FL 1060: a new beta-lactam antibiotic with novel properties. J Clin Pathol (1973) 2.95

Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrob Agents Chemother (1986) 2.68

The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms. J Exp Med (1948) 2.44

Global trends in rates of peritoneal dialysis. J Am Soc Nephrol (2012) 2.29

Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob Agents Chemother (2007) 1.99

Pharmaceutics of penicillin. J Pharm Sci (1962) 1.24

Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis. Am J Kidney Dis (2009) 1.16

In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid. Antimicrob Agents Chemother (1985) 1.12

Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model. Antimicrob Agents Chemother (2003) 1.09

Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Nephrol Dial Transplant (2009) 1.09

[Paradoxic bactericidal effect of penicillins on enterococci (Eagle effect)]. Dtsch Med Wochenschr (1973) 1.03

Factors affecting Staphylococcus epidermidis growth in peritoneal dialysis solutions. J Clin Microbiol (1986) 1.01

Intraperitoneal daptomycin used to successfully treat vancomycin-resistant enterococcus peritonitis. Perit Dial Int (2009) 0.98

Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis (2014) 0.98

Therapeutic serum concentrations of daptomycin after intraperitoneal administration in a patient with peritoneal dialysis-associated peritonitis. J Antimicrob Chemother (2010) 0.95

Daptomycin compatibility in peritoneal dialysis solutions. Perit Dial Int (2011) 0.94

Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them. Perit Dial Int (2005) 0.91

32 years' experience of peritoneal dialysis-related peritonitis in a university hospital. Perit Dial Int (2014) 0.90

Antibiotic stability in commercial peritoneal dialysis solutions: influence of formulation, storage and duration. Nephrol Dial Transplant (2011) 0.88

Evolution of microbiological trends and treatment outcomes in peritoneal dialysis-related peritonitis. Clin Nephrol (2011) 0.86

Effect of glucose concentration on the stability of daptomycin in peritoneal solutions. Perit Dial Int (2013) 0.85

Comparative in vitro antimicrobial activity of vancomycin, teicoplanin, daptomycin and ceftobiprole in four different peritoneal dialysis fluids. Eur J Clin Microbiol Infect Dis (2011) 0.81

Linezolid stability in peritoneal dialysis solutions. Perit Dial Int (2002) 0.78

Effect of peritoneal dialysis fluid and pH on bactericidal activity of ciprofloxacin. Antimicrob Agents Chemother (1987) 0.78

The effect of peritoneal dialysis solutions on rifampin action against Staphylococcus epidermidis in the fluid and biofilm phases of growth. Perit Dial Int (1993) 0.77

Stability of ampicillin and amoxicillin in peritoneal dialysis solutions. Am J Health Syst Pharm (2015) 0.77

Intraperitoneal antibiotics effectively treat non-dialysis-related infections. Perit Dial Int (1995) 0.77

Impact of various peritoneal dialysis solutions on the growth of common bacterial and yeast pathogens. Perit Dial Int (2011) 0.77

Successful treatment of vancomycin-resistant enterococcus peritonitis using linezolid without catheter removal in a peritoneal dialysis patient. Perit Dial Int (2014) 0.76

Articles by these authors

Compatibility of fosfomycin with different commercial peritoneal dialysis solutions. Eur J Clin Microbiol Infect Dis (2017) 0.75